
Sign up to save your podcasts
Or


Early reports revealed AstraZeneca's vaccine generates antibodies and T-Cells in the Oxford University phase 1 trial. The official data and results are set to be published today and could have a huge impact on the stock market.
By Dumb Money4.7
110110 ratings
Early reports revealed AstraZeneca's vaccine generates antibodies and T-Cells in the Oxford University phase 1 trial. The official data and results are set to be published today and could have a huge impact on the stock market.

3,392 Listeners

940 Listeners

1,987 Listeners

4,698 Listeners

393 Listeners

195 Listeners

1,852 Listeners

2,111 Listeners

242 Listeners

9,833 Listeners

734 Listeners

133 Listeners

534 Listeners

470 Listeners

508 Listeners